See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

Dr. Sheri Colberg Interviewed by Scott King

Dr. Sheri Colberg

Dr. Sheri Colberg Interviewed by Scott King

Injection Site Awareness Week

Dr. Stuart Bootle, MB ChB

Injection Site Awareness Week

STAT™ Medical Devices

Roger Huckleberry

STAT™ Medical Devices

Merck Archives

Merck

Updated 7 weeks ago
 
FDA Backtracks Over GLP-1s' Effects on Pancreas

The U.S. Food and Drug Administration reports that its review of various animal and human studies does not show a link between GLP-1 drugs used to treat type 2 diabetes and pancreatic maladies, including acute pancreatitis and pancreatic cancer.

Comments 0 comments - Mar 4, 2014 - * * * * *

An Interview With Mike Golic

Mike Golic is the co-host of ESPN's wildly popular radio show, "Mike and Mike in the Morning." Before beginning work as a broadcaster in 1995, he played for nine years as a defensive tackle in the National Football League, including stints with the Houston Oilers, Philadelphia Eagles, and Miami Dolphins. About five years ago, he was diagnosed with type 2 diabetes. Since then, he has become involved in getting the word out about type 2, including the potential danger of hypoglycemia. He is a spokesman for "Blood Sugar Basics," a website and outreach program co-sponsored by Merck and the American College of Endocrinology.

Comments 0 comments - Dec 21, 2012 - * * * * *

Lilly Says Its New Injectible Outperforms Three Popular Diabetes Drugs

Good news for Eli Lilly & Co., as well as for type 2s who appreciate the addition of new drugs to treat their condition: Lilly says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken diabetes drugs in three just-concluded Phase III studies.

Comments 0 comments - Nov 20, 2012 - * * * * *

The Game Plan: Blood Sugar Basics

How would you like an online interactive resource for type 2 diabetes that teaches you blood sugar basics? The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) have come together to develop "the Game Plan" diabetes management program. By going to the website at bloodsugarbasics.com/the-game-plan, you can get everyday tips, watch a video, take a quiz that tests your understanding of high and low blood sugar, and find advice on how to approach your healthcare team.

Comments 0 comments - Jun 12, 2012 - * * * * *

FDA OKs Sale of Combo Drug JANUMET® XR

The FDA has approved US sales of JANUMET® XR, a daily oral treatment for type 2 diabetes that combines sitagliptin and extended-release metformin. The drug is the fourth oral type 2 diabetes treatment introduced by Merck, which also sells JANUVIA, JANUMET, and JUVISYNC.

Comments 0 comments - Feb 6, 2012 - * * * * *

Are You Prepared for the Holidays?

If you have diabetes, you know all too well what's going to happen between now and the end of the year. You'll be forced to make some quick and painful decisions at sumptuous holiday feasts. Do you refuse the lavish, carbohydrate-rich fare and give up on the fun of the season? Or do you go whole hog, eating everything in sight, and hope that your insulin or medication can take up the slack?

Comments 3 comments - Dec 18, 2011 - * * * * *

New Type 2 Drug Targets Blood Sugar and Cholesterol

Drug company Merck aims to give people with type 2 diabetes two treatments for the price of one. The new therapy, called Juvisync, was just approved by the US Food and Drug Administration. It's not a radical new treatment, but instead a helpful combination of two familiar standbys: Juvisync unites the active ingredients in blood sugar-lowering Januvia and cholesterol-lowering Zocor in a single tablet.

Comments 0 comments - Dec 10, 2011 - * * * * *

An Interview With Mike Golic

Mike Golic is the co-host of ESPN's wildly popular radio show, "Mike and Mike in the Morning." Before beginning work as a broadcaster in 1995, he played for nine years as a defensive tackle in the National Football League, including stints with the Houston Oilers, Philadelphia Eagles, and Miami Dolphins. About five years ago, he was diagnosed with type 2 diabetes. Since then, he has become involved in getting the word out about type 2, including the potential danger of hypoglycemia. He is a spokesman for "Blood Sugar Basics," a website and outreach program co-sponsored by Merck and the American College of Endocrinology.

Comments 3 comments - Nov 25, 2011 - * * * * *

 
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.